These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1211 related items for PubMed ID: 24442917

  • 1. Helminth therapy (worms) for induction of remission in inflammatory bowel disease.
    Garg SK, Croft AM, Bager P.
    Cochrane Database Syst Rev; 2014 Jan 20; 2014(1):CD009400. PubMed ID: 24442917
    [Abstract] [Full Text] [Related]

  • 2. Fecal transplantation for treatment of inflammatory bowel disease.
    Imdad A, Nicholson MR, Tanner-Smith EE, Zackular JP, Gomez-Duarte OG, Beaulieu DB, Acra S.
    Cochrane Database Syst Rev; 2018 Nov 13; 11(11):CD012774. PubMed ID: 30480772
    [Abstract] [Full Text] [Related]

  • 3. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    Gordon M, Taylor K, Akobeng AK, Thomas AG.
    Cochrane Database Syst Rev; 2014 Aug 01; 2014(8):CD010233. PubMed ID: 25081347
    [Abstract] [Full Text] [Related]

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 5. Cannabis for the treatment of Crohn's disease.
    Kafil TS, Nguyen TM, MacDonald JK, Chande N.
    Cochrane Database Syst Rev; 2018 Nov 08; 11(11):CD012853. PubMed ID: 30407616
    [Abstract] [Full Text] [Related]

  • 6. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC, Wang Y, MacDonald JK, Hanauer S.
    Cochrane Database Syst Rev; 2016 Jul 03; 7(7):CD008870. PubMed ID: 27372735
    [Abstract] [Full Text] [Related]

  • 7. Cannabis for the treatment of ulcerative colitis.
    Kafil TS, Nguyen TM, MacDonald JK, Chande N.
    Cochrane Database Syst Rev; 2018 Nov 08; 11(11):CD012954. PubMed ID: 30406638
    [Abstract] [Full Text] [Related]

  • 8. Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease.
    Davies SC, Nguyen TM, Parker CE, MacDonald JK, Jairath V, Khanna R.
    Cochrane Database Syst Rev; 2019 Dec 12; 12(12):CD012804. PubMed ID: 31828765
    [Abstract] [Full Text] [Related]

  • 9. Etrolizumab for induction of remission in ulcerative colitis.
    Rosenfeld G, Parker CE, MacDonald JK, Bressler B.
    Cochrane Database Syst Rev; 2015 Dec 02; 2015(12):CD011661. PubMed ID: 26630451
    [Abstract] [Full Text] [Related]

  • 10. Antibiotics for induction and maintenance of remission in Crohn's disease.
    Townsend CM, Parker CE, MacDonald JK, Nguyen TM, Jairath V, Feagan BG, Khanna R.
    Cochrane Database Syst Rev; 2019 Feb 07; 2(2):CD012730. PubMed ID: 30731030
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Low dose naltrexone for induction of remission in Crohn's disease.
    Parker CE, Nguyen TM, Segal D, MacDonald JK, Chande N.
    Cochrane Database Syst Rev; 2018 Apr 01; 4(4):CD010410. PubMed ID: 29607497
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enteral nutrition for maintenance of remission in Crohn's disease.
    Akobeng AK, Zhang D, Gordon M, MacDonald JK.
    Cochrane Database Syst Rev; 2018 Aug 11; 8(8):CD005984. PubMed ID: 30098021
    [Abstract] [Full Text] [Related]

  • 17. Adalimumab for induction of remission in Crohn's disease.
    Abbass M, Cepek J, Parker CE, Nguyen TM, MacDonald JK, Feagan BG, Khanna R, Jairath V.
    Cochrane Database Syst Rev; 2019 Nov 14; 2019(11):. PubMed ID: 31742665
    [Abstract] [Full Text] [Related]

  • 18. Dietary interventions for induction and maintenance of remission in inflammatory bowel disease.
    Limketkai BN, Iheozor-Ejiofor Z, Gjuladin-Hellon T, Parian A, Matarese LE, Bracewell K, MacDonald JK, Gordon M, Mullin GE.
    Cochrane Database Syst Rev; 2019 Feb 08; 2(2):CD012839. PubMed ID: 30736095
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.